Area of research
Infectious Diseases · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research, Animal Virus Infections Studies, and COVID-19 Clinical Research Studies.
Nanocellulose Hybrid Membranes for Green Flexible Electronics: Interface Design and Functional Assemblies
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses
NMR Based SARS-CoV-2 Antibody Screening
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Structural basis of a shared antibody response to SARS-CoV-2
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain
Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits
Pyruvate kinase from Plasmodium falciparum: Structural and kinetic insights into the allosteric mechanism
Pyruvate Kinase Regulates the Pentose-Phosphate Pathway in Response to Hypoxia in Mycobacterium tuberculosis
CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling
Allosteric pyruvate kinase-based “logic gate” synergistically senses energy and sugar levels in Mycobacterium tuberculosis